Process Research and Impurity Control Strategy for Obeticholic Acid, a Farnesoid X Receptor Agonist

2019 ◽  
Vol 23 (9) ◽  
pp. 1979-1989
Author(s):  
Wei-Dong Feng ◽  
Song-Ming Zhuo ◽  
Fu-Li Zhang
Keyword(s):  
Control Strategy ◽  
Receptor Agonist ◽  
Process Research ◽  
Farnesoid X Receptor ◽  
Obeticholic Acid ◽  
Impurity Control

Tu1263 The Effects of Obeticholic Acid, a Farnesoid X Receptor Agonist, in Patients With Chronic Diarrhea Secondary to Crohn's Ileal Disease

2014 ◽  
Vol 146 (5) ◽  
pp. S-797
Author(s):  
Jonathan D. Nolan ◽  
Claire Vassie ◽  
Ian M. Johnston ◽  
Tracy Dew ◽  
David Shapiro ◽  
...  
Keyword(s):  
Receptor Agonist ◽  
Chronic Diarrhea ◽  
Farnesoid X Receptor ◽  
Obeticholic Acid ◽  
Ileal Disease

scholarly journals The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid

2014 ◽  
Vol 41 (1) ◽  
pp. 54-64 ◽  
Author(s):  
J. R. F. Walters ◽  
I. M. Johnston ◽  
J. D. Nolan ◽  
C. Vassie ◽  
M. E. Pruzanski ◽  
...  
Keyword(s):  
Bile Acid ◽  
Receptor Agonist ◽  
Farnesoid X Receptor ◽  
Obeticholic Acid

657 The First New Trials for Primary Biliary Cirrhosis in a Decade: An International Program Evaluating the Farnesoid X Receptor Agonist Obeticholic Acid

2015 ◽  
Vol 148 (4) ◽  
pp. S-991-S-992
Author(s):  
Kris Kowdley ◽  
Frederik Nevens ◽  
Pietro Andreone ◽  
Velimir A. Luketic ◽  
Hemant Shah ◽  
...  
Keyword(s):  
Primary Biliary Cirrhosis ◽  
Receptor Agonist ◽  
Farnesoid X Receptor ◽  
Biliary Cirrhosis ◽  
Obeticholic Acid ◽  
International Program

scholarly journals Tu1262 Obeticholic Acid, a Farnesoid X Receptor Agonist, Reduces Bile Acid Synthesis in Patients With Primary Bile Acid Diarrhea

2014 ◽  
Vol 146 (5) ◽  
pp. S-797 ◽  
Author(s):  
Claire Vassie ◽  
Jonathan D. Nolan ◽  
Ian M. Johnston ◽  
David Shapiro ◽  
Julian R. Walters
Keyword(s):  
Bile Acid ◽  
Receptor Agonist ◽  
Acid Synthesis ◽  
Bile Acid Synthesis ◽  
Farnesoid X Receptor ◽  
Obeticholic Acid ◽  
Primary Bile Acid

scholarly journals OP02 The first new monotherapy therapeutic PBC study in a decade? An international study evaluating the farnesoid X receptor agonist obeticholic acid in PBC

Gut ◽  
2011 ◽  
Vol 60 (Suppl 2) ◽  
pp. A50-A50 ◽  
Author(s):  
D. Jones ◽  
K. Kowdley ◽  
R. Chapman ◽  
A. Burroughs ◽  
G. Hirschfield ◽  
...  
Keyword(s):  
Receptor Agonist ◽  
International Study ◽  
Farnesoid X Receptor ◽  
Obeticholic Acid
Sign in / Sign up

Export Citation Format

Share Document